Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 12Breast 6Thoracic 4Gynecologic 3Tumor-Agnostic 2Other 2Head & Neck 2Plasma cell 1Genitourinary 1

Conditions

Neoplasms, Second Primary 1Neoplasms 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Probiotics × Tumor-Agnostic × Clear all
NCT06998823 2025-05-31

The Effect of Survival, Response and Microbiota Change in Different Therapy Under Probiotic Supplement

Chang Gung Memorial Hospital

Phase NA Recruiting
120 enrolled
Tumor-Agnostic

Neoplasms, Second Primary

NCT01706393 2013-04-19

RTxIMprobio

Seoul National University Hospital

Phase NA Unknown
26 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡